Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

Semmelweis Egyetem, Budapest

General Hospital Slovenj Gradec, Slovenj Gradec

Royal Melbourne Hospital, Parkville

Haukeland University Hospital Klinisk Forskningspost, Bergen

Vseobecna fakultni nemocnice v Praze, Prague

University of Pittsburgh, Pittsburgh

O+O Alpan LLC, Fairfax

Emory University School of Medicine, Atlanta

University of Florida, Gainesville

UAB Medicine, Birmingham

Cincinnati Children's Hospital Medical Center, Cincinnati

Infusion Associates, Grand Rapids

Hospital de Dia Quiron Zaragoza, Zaragoza

University of Iowa Hospitals and Clinics, Iowa City

Medical College of Wisconsin, Milwaukee

Renal Disease Research Institute, LLC - Dallas, Dallas

Institute of Metabolic Disease, Dallas

"Azienda Ospedaliera Universitaria Federico II", Napoli

University of Utah Hospitals & Clinics, Salt Lake City

Phoenix Children's Hospital, Phoenix

University of California San Diego, La Jolla

Hospital Raymond-Poincaré, Garches

University of California Irvine Center, Orange

Capital District Health Authority, Halifax

Turku University Central Hospital, Turku

Academisch Medisch Centrum, Amsterdam

University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Edgbaston

Salford Royal, Salford

Addenbrooke's Hospital, Cambridge

The Royal Free Hospital, London